Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome

M.A. Sanz; P. Montesinos; C. Rayon; A. Holowiecka; J. de la Serna; G. Milone; E. de Lisa; S. Brunet; V. Rubio; J.M. Ribera; C Rivas; I. Krsnik; J. Bergua; J. Gonzalez; J. Diaz-Mediavilla; R. Rojas; F. Manso; G.J. Ossenkoppele; J.D. Gonzalez; B. Lowenberg; G. Pethema; G. Hovon

doi:https://doi.org/10.1182/blood-2010-01-266007

Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome

M.A. Sanz, P. Montesinos, C. Rayon, A. Holowiecka, J. de la Serna, G. Milone, E. de Lisa, S. Brunet, V. Rubio, J.M. Ribera, C Rivas, I. Krsnik, J. Bergua, J. Gonzalez, J. Diaz-Mediavilla, R. Rojas, F. Manso, G.J. Ossenkoppele, J.D. Gonzalez, B. LowenbergG. Pethema, G. Hovon

Hematology (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

259 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	5137-5146
Journal	Blood
Volume	115
Issue number	25
DOIs	https://doi.org/10.1182/blood-2010-01-266007
Publication status	Published - 2010

Access to Document

https://doi.org/10.1182/blood-2010-01-266007

Cite this

Sanz, M. A., Montesinos, P., Rayon, C., Holowiecka, A., de la Serna, J., Milone, G., de Lisa, E., Brunet, S., Rubio, V., Ribera, J. M., Rivas, C., Krsnik, I., Bergua, J., Gonzalez, J., Diaz-Mediavilla, J., Rojas, R., Manso, F., Ossenkoppele, G. J., Gonzalez, J. D., ... Hovon, G. (2010). Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome. Blood, 115(25), 5137-5146. https://doi.org/10.1182/blood-2010-01-266007

@article{67c5c6676d4245a5bca7a26ed4fa0581,

title = "Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome",

author = "M.A. Sanz and P. Montesinos and C. Rayon and A. Holowiecka and {de la Serna}, J. and G. Milone and {de Lisa}, E. and S. Brunet and V. Rubio and J.M. Ribera and C Rivas and I. Krsnik and J. Bergua and J. Gonzalez and J. Diaz-Mediavilla and R. Rojas and F. Manso and G.J. Ossenkoppele and J.D. Gonzalez and B. Lowenberg and G. Pethema and G. Hovon",

year = "2010",

doi = "https://doi.org/10.1182/blood-2010-01-266007",

language = "Undefined/Unknown",

volume = "115",

pages = "5137--5146",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "25",

}

Sanz, MA, Montesinos, P, Rayon, C, Holowiecka, A, de la Serna, J, Milone, G, de Lisa, E, Brunet, S, Rubio, V, Ribera, JM, Rivas, C, Krsnik, I, Bergua, J, Gonzalez, J, Diaz-Mediavilla, J, Rojas, R, Manso, F, Ossenkoppele, GJ, Gonzalez, JD, Lowenberg, B, Pethema, G & Hovon, G 2010, 'Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome', Blood, vol. 115, no. 25, pp. 5137-5146. https://doi.org/10.1182/blood-2010-01-266007

Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome. / Sanz, M.A.; Montesinos, P.; Rayon, C. et al.
In: Blood, Vol. 115, No. 25, 2010, p. 5137-5146.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome

AU - Sanz, M.A.

AU - Montesinos, P.

AU - Rayon, C.

AU - Holowiecka, A.

AU - de la Serna, J.

AU - Milone, G.

AU - de Lisa, E.

AU - Brunet, S.

AU - Rubio, V.

AU - Ribera, J.M.

AU - Rivas, C

AU - Krsnik, I.

AU - Bergua, J.

AU - Gonzalez, J.

AU - Diaz-Mediavilla, J.

AU - Rojas, R.

AU - Manso, F.

AU - Ossenkoppele, G.J.

AU - Gonzalez, J.D.

AU - Lowenberg, B.

AU - Pethema, G.

AU - Hovon, G.

PY - 2010

Y1 - 2010

U2 - https://doi.org/10.1182/blood-2010-01-266007

DO - https://doi.org/10.1182/blood-2010-01-266007

M3 - Article

C2 - 20393132

SN - 0006-4971

VL - 115

SP - 5137

EP - 5146

JO - Blood

JF - Blood

IS - 25

ER -

Sanz MA, Montesinos P, Rayon C, Holowiecka A, de la Serna J, Milone G et al. Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome. Blood. 2010;115(25):5137-5146. doi: https://doi.org/10.1182/blood-2010-01-266007